Cargando…
Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
Lung cancer has become the primary cause of cancer-related deaths because of its high recurrence rate, ability to metastasise easily, and propensity to develop drug resistance. The wide-ranging heterogeneity of lung cancer subtypes increases the complexity of developing effective therapeutic interve...
Autores principales: | Zhu, Leqing, Zhang, Jianhua, Guo, Quanwei, Kuang, Jun, Li, Dongfang, Wu, Mengxi, Mo, Yijun, Zhang, Tao, Gao, Xinghua, Tan, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662056/ https://www.ncbi.nlm.nih.gov/pubmed/38026900 http://dx.doi.org/10.3389/fbioe.2023.1299033 |
Ejemplares similares
-
Biomimetic lung-on-a-chip to model virus infection and drug evaluation
por: Tan, Jianfeng, et al.
Publicado: (2023) -
Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
por: Zeng, Xiao, et al.
Publicado: (2023) -
Review on the Vascularization of Organoids and Organoids-on-a-Chip
por: Zhao, Xingli, et al.
Publicado: (2021) -
Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities
por: Chen, Jingyao, et al.
Publicado: (2022) -
Commentary: Human brain organoid-on-a-chip to model prenatal nicotine exposure
por: Qiao, Haowen, et al.
Publicado: (2018)